Page 110 - 《中国药房》2022年10期
P. 110
the care of kidney transplant recipients[J]. Am J Trans- [14] YIN S F,SONG T R,JIANG Y M,et al. Tacrolimus
plant,2009,9(Suppl 3):S1-S155. trough level at the first month may predict renal transplan-
[ 3 ] SINGH P,NG Y H,UNRUH M. Kidney transplantation tation outcomes among living Chinese kidney transplant
among the elderly:challenges and opportunities to im- patients:a propensity score-matched analysis[J]. Ther
prove outcomes[J]. Adv Chronic Kidney Dis,2016,23 Drug Monit,2019,41(3):308-316.
(1):44-50. [15] JIANG Y M,SONG T R,QIU Y,et al. Outcomes of sin-
[ 4 ] RIELLA L V. Understanding the causes of mortality post- gle kidney transplantation from pediatric donors:a sin-
transplantation:there is more than meets the eye[J]. J Bras gle-center experience[J]. Pediatr Transplant,2018,22(5):
Nefrol,2018,40(2):102-104. e13196.
[ 5 ] HOSOHATA K,MATSUOKA E,INADA A,et al. Dif- [16] 中华医学会器官移植学分会,中国医师协会器官移植医
ferential profiles of adverse events associated with myco- 师分会.中国活体供肾移植临床指南:2016版[J].器官移
phenolate mofetil between adult and pediatric renal trans- 植,2016,7(6):417-426.
plant patients[J]. J Int Med Res,2018,46(11):4617- [17] YARLAGADDA S G,COCA S G,GARG A X,et al.
4623. Marked variation in the definition and diagnosis of de-
[ 6 ] CHHABRA D,SKARO A I,LEVENTHAL J R,et al. layed graft function:a systematic review[J]. Nephrol Dial
Long-term kidney allograft function and survival in pred- Transplant,2008,23(9):2995-3003.
nisone-free regimens:tacrolimus/mycophenolate mofetil
[18] MALLON D H,SUMMERS D M,BRADLEY J A,et al.
versus tacrolimus/sirolimus[J]. Clin J Am Soc Nephrol,
Defining delayed graft function after renal transplantation:
2012,7(3):504-512.
simplest is best[J]. Transplantation,2013,96(10):885-
[ 7 ] 中华医学会器官移植学分会.器官移植免疫抑制剂临床
889.
应用技术规范:2019 版[J].器官移植,2019,10(3):213-
[19] 中华医学会器官移植学分会.器官移植受者巨细胞病毒
226.
感染临床诊疗规范:2019 版[J].器官移植,2019,10(2):
[ 8 ] ZHANG J,LUO Y G,ZHU Z F,et al. Pharmacokinetic
142-148.
comparison of two mycophenolate mofetil formulations in
[20] 中华医学会器官移植学分会,中国医师协会器官移植医
kidney transplant recipients[J]. Ther Drug Monit,2018,40
师分会.中国实体器官移植受者侵袭性真菌病临床诊治
(5):649-654.
指南:2016 年版[J].中华器官移植杂志,2016,37(6):
[ 9 ] CAI W,CAI Q,XIONG N,et al. Limited sampling strate-
300-305.
gy for estimating mycophenolic acid exposure on day 7
[21] 中华人民共和国卫生部.血细胞分析参考区间:WS/T
post-transplant for two mycophenolate mofetil formula-
405-2012[S/OL].[2021-11-30]. http://www.nhc.gov.cn/wjw/
tions derived from 20 Chinese renal transplant recipients
s9492/201301/d893733b674945afa63bc33f3cc7e60d.shtml.
[J]. Transplant Proc,2018,50(5):1298-1304.
[22] KIM S J,SCHAUBEL D E,FENTON S S A,et al. Morta-
[10] 石炳毅,于立新,陈立中,等.不同剂型吗替麦考酚酯用于
lity after kidney transplantation:a comparison between
同种肾移植的有效性和安全性比较[J].中华泌尿外科杂
the United States and Canada[J]. Am J Transplant,2006,6
志,2007,28(11):725-728.
(1):109-114.
[11] 李玉凤,张胜利,姚家琳,等.关于国产吗替麦考酚酯分散
[23] WADHWA R K,NAZEER A,RAI A A,et al. Role of
片与进口胶囊预防肾移植术后急性排斥反应的比较[J].
endoscopic findings and biopsies in renal transplant reci-
临床荟萃,2010,25(13):1134-1137.
[12] 张彦选,曲青山,苗书斋,等.吗替麦考酚酯分散片在活体 pients with gastrointestinal complications:a tertiary care
亲属肾移植后早期应用:与吗替麦考酚酯胶囊的对 experience[J]. Exp Clin Transplant,2018,16(5):522-
比[J].中国组织工程研究与临床康复,2010,14(31): 527.
5709-5712. [24] 孙雯,郭宏波,解泽林,等.肾移植患者术后腹泻的相关因
[13] WANG X D,LIU J P,FAN Y,et al. Individualized precon- 素分析[J].北京大学学报(医学版),2013,45(5):779-
ditioning for ABO-incompatible living-donor kidney trans- 781.
plantation:an initial report of 48 cases from China[J]. Ann (收稿日期:2021-11-05 修回日期:2022-04-28)
Transplant,2020,25:e920224. (编辑:胡晓霖)
·1252 · China Pharmacy 2022 Vol. 33 No. 10 中国药房 2022年第33卷第10期